Risk of cardiovascular disease in HIV-infected patients

Satyajit Das1

  • 1HIV & GU Medicine, Coventry Community Health Services, Stoney Stanton Road, Coventry CV1 4FH, UK. satyajit.das@coventrypct.nhs.uk

Insights

Highly active antiretroviral therapy (HAART) has significantly increased HIV life expectancy. Long-term HIV management now requires addressing age-related conditions like cardiovascular disease (CVD).

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Gerontology

Background:

  • The advent of highly active antiretroviral therapy (HAART) has transformed HIV infection from a terminal illness into a chronic condition.
  • Increased life expectancy for people with HIV necessitates a shift in treatment focus towards long-term health management.
  • Age-associated comorbidities, particularly cardiovascular disease (CVD), are emerging as significant concerns in the aging HIV population.

Purpose of the Study:

  • To explore and discuss the evidence linking HIV infection to increased cardiovascular risk.
  • To examine the potential cardiovascular risks associated with antiretroviral therapy (ART).
  • To highlight the importance of managing age-related diseases in long-term HIV care.

Main Methods:

  • Literature review of studies investigating cardiovascular risk in HIV-infected individuals.
  • Analysis of data on the association between specific antiretroviral drugs and cardiovascular events.
  • Synthesis of current understanding regarding HIV-related inflammation and its impact on cardiovascular health.

Main Results:

  • Evidence suggests that HIV infection itself is an independent risk factor for cardiovascular disease.
  • Certain antiretroviral therapies may be associated with an elevated risk of cardiovascular complications.
  • The interplay between HIV, aging, and traditional cardiovascular risk factors requires careful consideration.

Conclusions:

  • Long-term management of HIV must prioritize the prevention and treatment of cardiovascular disease.
  • Further research is needed to fully elucidate the mechanisms of cardiovascular risk in HIV and to optimize ART regimens for cardiovascular safety.
  • A comprehensive approach integrating infectious disease and cardiovascular care is essential for improving outcomes in aging individuals with HIV.

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...